A Study of Tadalafil for Duchenne Muscular Dystrophy

Clinical trial NCT01865084 · TERMINATED

Trial details

NCT number: NCT01865084
Sponsor: Eli Lilly and Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Muscular Dystrophy, Duchenne

Start date: 2013-09-01
Primary completion: 2015-12-01
Enrollment: 331

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.